Begoña Mellado González

2PUBLICATIONS
10CO-AUTHORS
Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

Sort by Publication Date:
|Jul 26, 2022
Single-nucleotide polymorphism associations with efficacy and toxicity in metastatic castration-resistant prostate cancer treated with cabazitaxel.

Daniel Herrero Rivera, Carmen Garrigós Vacas, Laura Marcos Kovandzic

|Feb 27, 2019
The influence of treatment sequence in the prognostic value of TMPRSS2-ERG as biomarker of taxane resistance in castration-resistant prostate cancer.

Mercedes Marín-Aguilera, Òscar Reig, Maria Milà-Guasch

Pageof 1

Frequent Collaborators

1 joint publications

Daniel Herrero Rivera

1 joint publications

Carmen Garrigós Vacas

1 joint publications

Javier Puente Vázquez

1 joint publications

Enrique Grande

1 joint publications

Raquel Luque Caro

1 joint publications

Juan A Virizuela Echaburu

1 joint publications

Juan F Rodríguez Moreno

1 joint publications

Ainara A Etxebarria

1 joint publications

Cristina Rodríguez-Antona

1 joint publications

Ignacio Durán

Frequent Collaborators

1 joint publications

Daniel Herrero Rivera

1 joint publications

Carmen Garrigós Vacas

1 joint publications

Javier Puente Vázquez

1 joint publications

Enrique Grande

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel
06:44

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel

Published on : Sep 08, 2017

13.5K
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on : Mar 06, 2018

13.7K
See more related videos

Top Related Videos

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel
06:44

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel

Published on : Sep 08, 2017

13.5K
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on : Mar 06, 2018

13.7K
See more related videos